212 related articles for article (PubMed ID: 16291812)
21. Proteinase 3, Wegener's autoantigen: from gene to antigen.
van der Geld YM; Limburg PC; Kallenberg CG
J Leukoc Biol; 2001 Feb; 69(2):177-90. PubMed ID: 11272267
[TBL] [Abstract][Full Text] [Related]
22. 'Classic' anti-neutrophil cytoplasmic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis.
Gross WL; Csernok E; Flesch BK
J Autoimmun; 1993 Apr; 6(2):171-84. PubMed ID: 8388690
[TBL] [Abstract][Full Text] [Related]
23. A novel system to test for specificity of B cell receptors from tissue of Wegener's granulomatosis patients.
Voswinkel J; Kerkdijk AJ; Mueller A; Assmann G; Pfreundschuh M; Held G
Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S90-6. PubMed ID: 18799062
[TBL] [Abstract][Full Text] [Related]
24. Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides.
Bonaci-Nikolic B; Nikolic MM; Andrejevic S; Zoric S; Bukilica M
Arthritis Res Ther; 2005; 7(5):R1072-81. PubMed ID: 16207324
[TBL] [Abstract][Full Text] [Related]
25. Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma.
Baslund B; Petersen J; Permin H; Wiik A; Wieslander J
J Immunol Methods; 1994 Oct; 175(2):215-25. PubMed ID: 7930650
[TBL] [Abstract][Full Text] [Related]
26. Expression of the human autoantigen of Wegener's granulomatosis (PR3) in a baculovirus expression system.
Szymkowiak CH; Johnston TW; Csernok E; Gross WL
Biochem Biophys Res Commun; 1996 Feb; 219(2):283-9. PubMed ID: 8604978
[TBL] [Abstract][Full Text] [Related]
27. Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener's granulomatosis.
Zhou Y; Huang D; Farver C; Hoffman GS
J Rheumatol; 2003 Jul; 30(7):1541-7. PubMed ID: 12858455
[TBL] [Abstract][Full Text] [Related]
28. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils.
Van Rossum AP; van der Geld YM; Limburg PC; Kallenberg CG
Kidney Int; 2005 Aug; 68(2):537-41. PubMed ID: 16014030
[TBL] [Abstract][Full Text] [Related]
29. Wegener's granulomatosis--autoimmunity to neutrophil proteinase 3.
Watorek E; Boratyńska M; Klinger M
Arch Immunol Ther Exp (Warsz); 2003; 51(3):157-67. PubMed ID: 12894870
[TBL] [Abstract][Full Text] [Related]
30. Activation, apoptosis, and clearance of neutrophils in Wegener's granulomatosis.
van Rossum AP; Limburg PC; Kallenberg CG
Ann N Y Acad Sci; 2005 Jun; 1051():1-11. PubMed ID: 16126939
[TBL] [Abstract][Full Text] [Related]
31. Amphipathic variable region heavy chain peptides derived from monoclonal human Wegener's anti-PR3 antibodies stimulate lymphocytes from patients with Wegener's granulomatosis and microscopic polyangiitis.
Peen E; Malone C; Myers C; Williams RC; Peck AB; Csernok E; Gross WL; Staud R
Clin Exp Immunol; 2001 Aug; 125(2):323-31. PubMed ID: 11529926
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of proteinase 3 by ANCA and its correlation with disease activity in Wegener's granulomatosis.
Daouk GH; Palsson R; Arnaout MA
Kidney Int; 1995 Jun; 47(6):1528-36. PubMed ID: 7643521
[TBL] [Abstract][Full Text] [Related]
33. Complexes between proteinase 3, alpha 1-antitrypsin and proteinase 3 anti-neutrophil cytoplasm autoantibodies: a comparison between alpha 1-antitrypsin PiZ allele carriers and non-carriers with Wegener's granulomatosis.
Baslund B; Szpirt W; Eriksson S; Elzouki AN; Wiik A; Wieslander J; Petersen J
Eur J Clin Invest; 1996 Sep; 26(9):786-92. PubMed ID: 8889441
[TBL] [Abstract][Full Text] [Related]
34. Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis.
van der Geld YM; Tool AT; Videler J; de Haas M; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG; Roos D
Clin Exp Immunol; 2002 Sep; 129(3):562-70. PubMed ID: 12197900
[TBL] [Abstract][Full Text] [Related]
35. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study.
Boomsma MM; Stegeman CA; van der Leij MJ; Oost W; Hermans J; Kallenberg CG; Limburg PC; Tervaert JW
Arthritis Rheum; 2000 Sep; 43(9):2025-33. PubMed ID: 11014352
[TBL] [Abstract][Full Text] [Related]
36. Proteinase 3 gene polymorphisms and Wegener's granulomatosis.
Gencik M; Meller S; Borgmann S; Fricke H
Kidney Int; 2000 Dec; 58(6):2473-7. PubMed ID: 11115080
[TBL] [Abstract][Full Text] [Related]
37. Current knowledge on cellular interactions in the WG-granuloma.
Lamprecht P; Gross WL
Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S49-51. PubMed ID: 17428367
[TBL] [Abstract][Full Text] [Related]
38. Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis.
Choi HK; Merkel PA; Tervaert JW; Black RM; McCluskey RT; Niles JL
Arthritis Rheum; 1999 Feb; 42(2):384-8. PubMed ID: 10025935
[TBL] [Abstract][Full Text] [Related]
39. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
[TBL] [Abstract][Full Text] [Related]
40. Wegener's granulomatosis associated with renal cell carcinoma.
Tatsis E; Reinhold-Keller E; Steindorf K; Feller AC; Gross WL
Arthritis Rheum; 1999 Apr; 42(4):751-6. PubMed ID: 10211890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
